Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Neoplasms × Taxes × Clear all

Sponsor

Conditions

Breast Neoplasms 47 Fallopian Tube Neoplasms 22 Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 17 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 11 Breast Neoplasms, Male 11 Lung Neoplasms 9 Brenner Tumor 9 Inflammatory Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Melanoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Adenocarcinoma Of Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Pleural Effusion, Malignant 3 Endometrial Adenocarcinoma 3 Cholangiocarcinoma 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Thymoma 2 Pancreatic Adenocarcinoma 2 Neurotoxicity Syndromes 2 Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2 Brain Neoplasms 2

Interventions

pembrolizumab 4 Gemcitabine 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Bupropion 2 tocilizumab 1 tislelizumab 1 spartalizumab 1 infigratinib 1 etoposide phosphate 1 cc-486 1 avelumab 1 Zoledronic Acid 1 Vorinostat 1 Tobacco Use Cessation Devices 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Pilocarpine 1 Oral Hygiene 1 Ifosfamide 1 Gene Expression Profiling 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Etoposide 1 Early Intervention, Educational 1 Dexamethasone 1 Counseling 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡